Cryolife inc. (CRY)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Net cash flows from operating activities:
Net loss

-6,665

-681

-134

2,832

-297

-776

1,565

226

-3,855

-3,007

1,325

3,163

2,223

2,897

2,993

2,347

2,541

2,636

2,145

-502

-274

1,776

2,326

2,161

1,059

9,026

3,169

1,785

2,192

2,083

1,538

3,334

991

1,866

2,019

1,820

1,666

Adjustments to reconcile net loss to net cash from operating activities:
Depreciation and amortization

4,898

5,060

4,526

4,380

4,351

4,459

4,531

4,729

4,376

3,062

2,331

2,184

2,168

2,136

2,159

2,160

1,929

1,324

1,428

1,556

1,555

1,560

1,531

1,475

1,462

1,430

1,473

1,487

1,453

1,457

1,441

1,357

1,378

1,403

1,362

1,178

1,017

Non-cash compensation

2,564

2,218

2,462

2,269

1,850

1,640

1,568

1,869

1,248

1,267

1,856

2,000

1,796

1,711

1,748

1,456

1,413

1,362

553

2,037

1,137

700

1,092

799

845

883

799

776

782

911

755

743

753

650

696

671

773

Deferred income taxes

265

-

-

-123

424

-

-

1,588

1,283

-

-

215

-201

-

-

-

-

-

-

-

-

-

-

-

-

-1,577

486

287

187

409

-372

-1,102

-162

-1,808

-393

342

92

Gain from sale of business components

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

7,915

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other non-cash adjustments to net loss

-2,927

2,839

-989

-3,295

-737

-3,479

2,808

-668

-810

203

169

-624

-424

5,327

-899

-3,905

-791

3,046

-934

-1,786

-594

-70

153

32

359

835

-342

-393

-398

371

-597

-321

-136

-280

-277

-12

-198

Changes in operating assets and liabilities:
Receivables

-3,557

836

-5,950

7,154

3,292

-1,191

-4,410

3,374

3,346

2,955

342

5,100

-1,139

-413

-1,632

2,152

-4,249

2,229

1,254

1,543

-1,217

1,268

2,024

-1,429

2,693

-2,506

1,864

-1,042

3,321

-2,153

-5,921

5,909

802

2,231

-561

-1,413

1,973

Inventories and deferred preservation costs

2,874

4,261

4,126

1,134

-1,396

-687

-572

1,829

-2,954

2,468

2,878

2,621

1,402

3,721

1,366

1,613

2,760

1,570

822

-1,027

897

-992

392

910

821

377

-829

1,412

-1,153

233

72

557

736

-145

814

-5,372

2,258

Prepaid expenses and other assets

-982

3,157

-111

3,758

-627

-74

224

2,042

215

-72

-295

2,282

1,053

-561

-380

1,849

-1,423

-80

-116

1,655

-272

-385

548

2,178

430

-39

-371

1,489

-373

-209

-464

1,330

-74

-351

-60

1,440

-412

Accounts payable, accrued expenses, and other liabilities

-2,489

1,364

2,781

-107

-3,787

3,603

-4,165

2,108

-10,416

9,582

372

400

-1,627

4,416

391

174

-261

-2,164

1,733

2,081

-2,306

242

672

123

-1,101

956

1,667

2,335

-4,386

1,554

-4,936

4,062

-151

-1,416

2,047

-826

-577

Net cash flows provided by operating activities

2,635

1,060

12,860

746

1,161

10,521

8,320

767

-9,727

5,977

2,804

-1,847

3,869

5,045

8,836

4,428

1,410

1,415

4,833

3,896

1,298

4,785

2,504

2,867

-2,038

5,465

7,272

5,204

-1,169

7,982

6,080

3,123

1,805

3,044

5,815

4,026

3,866

Net cash flows from investing activities:
Decrease in restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

5,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Capital expenditures

2,539

2,850

1,878

2,150

1,194

1,511

922

1,237

2,116

1,248

1,049

2,301

2,034

2,687

1,903

788

820

304

994

1,137

1,055

1,085

953

1,235

1,037

1,097

984

1,269

988

860

662

848

700

545

807

912

274

Acquisition of JOTEC, net of cash acquired

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

91,152

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sale of business components

-

-

-

-

-

-

-

-

-

-

-

-

740

0

0

0

19,795

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other

364

340

229

69

233

207

444

275

3

19

843

-807

31

114

42

-8

-22

102

21

-8

495

-578

60

880

642

-169

44

31

84

-769

37

634

89

41

398

87

21

Net cash flows used in investing activities

-2,903

-3,190

-17,107

-2,219

-1,427

-1,718

-1,366

-1,512

-2,119

-166,337

-1,152

-2,234

-1,325

-7,801

-1,945

-2,006

-67,155

-1,683

-1,015

-238

-1,550

-546

-1,013

-2,115

-1,679

14,277

-1,028

-1,300

-1,072

-1,910

-1,684

-18,537

-789

-586

-4,774

-22,061

-295

Net cash flows from financing activities:
Proceeds from revolving line of credit

30,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repayment of term loan

691

708

679

697

696

692

698

693

707

1,078

938

2,509

469

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payment of debt issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

2,289

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of term loan

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

75,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of stock options and issuance of common stock

1,064

239

937

1,553

2,029

61

2,850

337

606

527

834

478

1,287

87

1,089

291

736

118

701

24

683

1,266

905

147

357

1,355

610

13

229

28

156

4

142

-9

288

265

150

Cash dividends paid

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

855

853

850

850

843

842

838

772

765

759

756

687

-

-

-

-

-

-

-

-

Repurchases of common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

145

175

1,203

-153

74

1,746

1,643

1,457

35

10

1,562

Redemption and repurchase of stock to cover tax withholdings

1,712

20

59

288

2,376

15

274

299

1,512

14

48

252

1,300

98

37

-1

563

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other

-146

-168

-211

-177

-172

-14

-196

-351

-341

-907

-1

-1

-1

46

225

118

228

1,267

75

-435

-449

1,415

-5

33

-705

320

-1

68

-474

-69

0

-8

-66

-367

-51

5

-63

Net cash flows provided by (used in) financing activities

28,515

-657

-12

391

-1,215

-1,284

1,682

-1,006

-1,954

146,165

-153

-2,284

-483

35

340

-59

73,112

-856

-77

-1,261

-616

-649

-2,519

-2,665

-1,120

229

-295

-850

-2,135

-794

-604

-1,750

-1,567

-1,833

202

260

-1,475

Effect of exchange rate changes on cash, cash equivalents, and restricted securities

1,336

-96

1,181

262

320

-594

956

78

439

-65

308

-24

193

101

-35

-255

-128

215

-319

265

-94

-38

-19

20

-43

-7

-2

46

-1

-59

-1

17

-8

30

6

-6

-11

Increase (decrease) in cash, cash equivalents, and restricted securities

29,583

-2,883

-3,078

-820

-1,161

6,925

9,592

-1,673

-13,361

-14,260

1,807

-6,389

2,254

-2,620

7,196

2,108

7,239

-909

3,422

2,662

-962

3,552

-1,047

-1,893

-4,880

19,964

5,947

3,100

-4,377

5,227

3,792

-17,164

-551

625

1,243

-17,775

2,096